![]() or its wholly owned subsidiaries in the United States and foreign countries. For more information, visit the Company’s website: Myriad, the Myriad logo, BART, BRAC Analysis, Colaris, Colaris AP, myPath, myRisk, Myriad myRisk, myRisk Hereditary Cancer, m圜hoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, m圜hoice CDx, Vectra, EndoPredict, Prequel, Foresight, GeneSight, riskScore and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs. Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and wellbeing for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease. Myriad Women’s Health offers the Myriad myRisk ® Hereditary Cancer test, Myriad Foresight ® Carrier Screen and Myriad Prequel™ Prenatal Screen as well as a suite of services to expand access and streamline the genetic testing process for patients and providers. “We are fortunate to have an executive of Melissa’s caliber as the most recent addition to our team.” #MYRIAD FORESIGHT CARRIER SCREEN FULL#She has the passion, leadership qualities, and proven experience to accelerate the growth of our Women’s Health business and elevate our products to their full potential,” said Lambert. “Melissa is a proven leader with deep relevant expertise both in partnering with healthcare systems as well as reaching patients directly. “She has the passion, leadership qualities, and proven experience to accelerate the growth of our Women’s Health business” She will report to Nicole Lambert, president of Myriad Genetic Laboratories. In her role at Myriad Women’s Health, Gonzales will be responsible for serving consumers, patients and healthcare providers with genetic tests that help women assess their risk of hereditary cancer and provide vital insights during pregnancy or when planning a family. Prior to Medela, Gonzales led commercial teams at Align Technology and Smith & Nephew. She served as executive vice president of Medela Americas and helped position the company as the number one breast pump brand in the United States. Gonzales has more than 20 years of women’s health experience, most recently at Medela, a global leader in breast pumps and medical solutions, supporting millions of new moms and babies. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced that Melissa Gonzales has been named president of its Women’s Health business. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |